Innate Pharma SA anounced its financial results for the first semester of 2007: operational execution according to plan; growth in revenue limits burn rate despite increase in R&D spending.
| PR in english | 82.38 KB |
| Interim financial report, June 30, 2007 | 199.1 KB |
| CP en français | 89.12 KB |
| Rapport financier semestriel, au 30 juin 2007 | 723.96 KB |